Browsing by Author 오성용[오성용]

Jump to:
All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 7 of 7

Issue DateTitleAuthor(s)
2012-02Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)김민경; 엄현석[엄현석]; 원영웅[원영웅]; 권정혜[권정혜]; 이순일[이순일]; 오성용[오성용]; 김원석[김원석]; 김석진[김석진]; 원종호[원종호]; 김경하[김경하]
2014-03Clinical features and treatment outcomes in patients with mantle cell lymphoma in Korea: Study by the consortium for improving survival of lymphoma김민경; 강병욱[강병욱]; 손상균[손상균]; 문준호[문준호]; 채이수[채이수]; 김종광[김종광]; 이수정[이수정]; 김원석[김원석]; 이제중[이제중]; 이세련[이세련]; 박건욱[박건욱]; 이호섭[이호섭]; 이원식[이원식]; 원종호[원종호]; 박무림[박무림]; 곽재용[곽재용]; 김호영[김호영]; 오성용[오성용]; 강혜진[강혜진]; 서철원[서철원]
2011-02Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone김민경; 김석진[김석진]; 강혜진[강혜진]; 김진석[김진석]; 오성용[오성용]; 최철원[최철원]; 이순일[이순일]; 원종호[원종호]; 권정혜[권정혜]; 서철원[서철원]; 김원석[김원석]
2011-07Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)김석진[김석진]; 김원석[김원석]; 김민경; 최철원[최철원]; 문영철[문영철]; 오성용[오성용]; 강혜진[강혜진]; 이순일[이순일]; 원종호[원종호]; 김진석[김진석]; 곽재용[곽재용]; 권정미[권정미]; 황인규[황인규]; 권정혜[권정혜]; 김효정[김효정]; 이재훈[이재훈]; 오석중[오석중]; 박건우[박건우]; 서철원[서철원]
2010-09Multiple mucosa-associated lymphoid tissue organs involving marginal zone B cell lymphoma: organ-specific relationships and the prognostic factors. Consortium for improving survival of lymphoma study김민경; 오성용[오성용]; 김원석[김원석]; 김진석[김진석]; 김석진[김석진]; 이수[이수]; 이대호[이대호]; 원종호[원종호]; 황인규[황인규]; 이순일[이순일]; 채이수[채이수]; 양덕환[양덕환]; 강혜진[강혜진]; 최철원[최철원]; 박지니[박지니]; 김효정[김효정]; 권정혜[권정혜]; 이호섭[이호섭]; 이경원[이경원]; 엄현석[엄현석]; 곽재용[곽재용]; 이원식[이원식]; 서철원[서철원]; 김효진[김효진]
2010-02Pulmonary marginal zone B-cell lymphoma of MALT type-What is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) Study김민경; 오성용[오성용]; 김원성[김원성]; 김진석[김진석]; 김석진[김석진]; 권혁찬[권혁찬]; 이대호[이대호]; 원종호[원종호]; 황인규[황인규]; 이순일[이순일]; 채이수[채이수]; 양덕환[양덕환]; 최철원[최철원]; 박지니[박지니]; 서철원[서철원]; 김효진[김효진]
2010-09Stage IV marginal zone B-cell lymphoma - prognostic factors and the role of rituximab: Consortium for Improving Survival of Lymphoma (CISL) study김민경; 오성용[오성용]; 김원석[김원석]; 김진석[김진석]; 김석진[김석진]; 이수[이수]; 이대호[이대호]; 원종호[원종호]; 황인규[황인규]; 이순일[이순일]; 채이수[채이수]; 양덕환[양덕환]; 강혜진[강혜진]; 최철원[최철원]; 박지니[박지니]; 김효정[김효정]; 권정혜[권정혜]; 이호섭[이호섭]; 이경원[이경원]; 엄현석[엄현석]; 곽재용[곽재용]; 서철원[서철원]; 김효진[김효진]

BROWSE